Last reviewed · How we verify
Acetatocobalamin (hydroxocobalamin acetate)
At a glance
| Generic name | hydroxocobalamin acetate |
|---|---|
| Drug class | Antidote |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health (NA)
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (PHASE2,PHASE3)
- Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
- Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility (NA)
- Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PHASE4)
- An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits (NA)
- Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetatocobalamin CI brief — competitive landscape report
- Acetatocobalamin updates RSS · CI watch RSS
- portfolio CI